Interestingly, analysis of gut-permeability markers in a longitudinal cohort of RA patients treated with the TNF inhibitor etanercept showed a partial restoration of gut integrity in patients responding to the treatment. The gene discussed is TNF; the disease is rheumatoid arthritis.